Director Bruce Bodaken of iRhythm (NASDAQ: IRTC) receives 1,573 RSUs in equity grant

Rhea-AI Filing Summary

Bodaken Bruce G. reported acquisition or exercise transactions in this Form 4 filing.

iRhythm Holdings director Bruce G. Bodaken received a stock-based award. He was granted 1,573 shares of common stock in the form of restricted stock units at no cash cost. Following this grant, he holds 14,211 shares directly. The RSUs vest on the earlier of one year after grant or the company’s next annual meeting.

Insights

Equity compensation analyst

Director received a routine RSU grant that modestly increases his equity stake.

Director Bruce G. Bodaken acquired 1,573 restricted stock units of iRhythm Holdings at a grant price of $0.00 per share. This is classified as a grant or award rather than an open-market purchase or sale.

The award brings his direct holdings to 14,211 common shares, indicating a relatively small but increasing ownership position. Because it is compensation-related, this event carries weaker signaling value than a discretionary market trade.

The RSUs vest on the earlier of one year after grant or the next annual meeting, meaning realizable value depends on continued service until that vesting date. Future filings may show additional grants or vesting activity that further change his equity exposure.

Insider Trade Summary

Net Buyer: 1,573 shares

Net Buy 1 txn

Insider Bodaken Bruce G.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,573	$0.00	$0.00

Holdings After Transaction: Common Stock — 14,211 shares (Direct)

Footnotes (1)

1. F1. These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting.

Key Figures

RSU grant size: 1,573 shares Grant price: $0.00 per share Shares held after grant: 14,211 shares

3 metrics

RSU grant size 1,573 shares Restricted stock units granted on May 27, 2026

Grant price $0.00 per share Equity award, not open-market purchase

Shares held after grant 14,211 shares Total direct common stock holdings post-transaction

Key Terms

restricted stock units ("RSUs"), contingent right, vesting

3 terms

restricted stock units ("RSUs") financial

"These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

contingent right financial

"Each RSU represents a contingent right to receive one share of IRTC Common Stock."

vesting financial

"The vesting occurs on the earlier of (i) one year after grant or (ii) the date of the company's next annual meeting."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

What did iRhythm Holdings (IRTC) director Bruce G. Bodaken report on this Form 4?

Bruce G. Bodaken reported receiving 1,573 restricted stock units of iRhythm Holdings common stock. The award was a stock-based grant at no cash cost and raised his direct holdings to 14,211 shares after the transaction.

How many iRhythm Holdings (IRTC) shares does Bruce G. Bodaken hold after the RSU grant?

After the reported grant, Bruce G. Bodaken directly holds 14,211 shares of iRhythm Holdings common stock. This total includes the 1,573 restricted stock units awarded in the transaction, which each represent a contingent right to one share upon vesting.

What type of equity award did Bruce G. Bodaken receive from iRhythm Holdings (IRTC)?

He received restricted stock units (RSUs), with each RSU representing a contingent right to one share of iRhythm Holdings common stock. These RSUs were granted as compensation, not purchased in the open market, and carry a vesting schedule tied to time and company events.

When do Bruce G. Bodaken’s iRhythm Holdings (IRTC) RSUs vest?

The RSUs vest on the earlier of one year after the grant date or the date of iRhythm Holdings’ next annual meeting. Vesting determines when each restricted stock unit converts into an actual share of common stock deliverable to the director.

Did Bruce G. Bodaken buy or sell iRhythm Holdings (IRTC) shares in the market?

He did not buy or sell shares in the open market. The Form 4 shows an acquisition coded as a grant or award of 1,573 restricted stock units at a grant price of $0.00 per share, reflecting equity compensation rather than a trading decision.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 05/29/2026 - 04:04 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bodaken Bruce G.

(Last) (First) (Middle)

C/O IRHYTHM HOLDINGS, INC.

699 8TH ST #600

(Street)

SAN FRANCISCO CALIFORNIA 94103

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
iRhythm Holdings, Inc. [ IRTC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/27/2026		A		1,573(1)	A	$0	14,211	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting.

Remarks:

On January 12, 2026, iRhythm Technologies, Inc. (iRhythm Tech) and iRhythm Holdings, Inc. (Issuer) effectuated a holding company reorganization pursuant to which the Issuer became the successor issuer to iRhythm Tech pursuant to Rule 12g-3(a) of the Securities Exchange Act of 1934, as amended. On such date, all outstanding shares and equity awards of iRhythm Tech automatically converted into securities of the Issuer on a one for one basis, with no change to the proportionate interests of security holders.

	/s/ Marc Rosenbaum, attorney-in-fact	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)